sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Endoscope - Radiofrequency Ablation (RFA) Market by Application (Cardiology, Applications, Pain Management, Oncology Applications, and Other Applications) - Global Opportunity Analysis and Industry Forecast, 2017-2025

Endoscope - Radiofrequency Ablation (RFA) Market by Application (Cardiology, Applications,...

Home / Categories / Healthcare
Endoscope - Radiofrequency Ablation (RFA) Market by Application (Cardiology, Applications, Pain Management, Oncology Applications, and Other Applications) - Global Opportunity Analysis and Industry Forecast, 2017-2025
Endoscope - Radiofrequency Ablation (RFA)...
Report Code
RO1/113/1396

Publish Date
01/Jul/2018

Pages
75
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Endoscope + radiofrequency ablation (RFA) market: Innovative products

3.2.1. Barex 360
3.2.2. Habib EUS RFA catheter
3.2.3. Temperature-resistant probes

3.3. Clinical trials: RFA and RFA + endoscope products in pipeline
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in the prevalence of cancer and cardiac ailments across the globe
3.4.1.2. Large scale adoption of endoscopic RFA devices in pain management
3.4.1.3. High efficacy and short duration of the procedure

3.4.2. Restraints

3.4.2.1. High costs associated with the RFA treatment
3.4.2.2. Limited awareness regarding available RFA + endoscope devices

3.4.3. Opportunity

3.4.3.1. Emerging indications for the endoscopic radiofrequency ablation

CHAPTER 4: ENDOSCOPE + RADIOFREQUENCY ABLATION (RFA) MARKET, BY APPLICATION

4.1. Overview

4.1.1. Market size and forecast

4.2. Oncology application

4.2.1. Market size and forecast

4.3. Pain management

4.3.1. Market size and forecast

4.4. Cardiology application

4.4.1. Market size and forecast

4.5. Other applications

4.5.1. Market size and forecast

CHAPTER 5: COMPANY PROFILES

5.1. Boston Scientific Corporation

5.1.1. Company overview
5.1.2. Company snapshot
5.1.3. Operating business segment
5.1.4. Business performance
5.1.5. Key strategic moves and developments

5.2. Conmed Corporation

5.2.1. Company overview
5.2.2. Company snapshot
5.2.3. Operating business segment
5.2.4. Business performance
5.2.5. Key strategic moves and developments

5.3. Medtronic Plc

5.3.1. Company overview
5.3.2. Company snapshot
5.3.3. Operating business segment
5.3.4. Business performance
5.3.5. Key strategic moves and developments

5.4. Smith & Nephew Plc

5.4.1. Company overview
5.4.2. Company snapshot
5.4.3. Operating business segment
5.4.4. Business performance

5.5. Stryker Corporation

5.5.1. Company overview
5.5.2. Company snapshot
5.5.3. Operating business segments
5.5.4. Business performance
5.5.5. Key strategic moves and developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com